Status:
UNKNOWN
Treatment of Philadelphia-Positive Acute Lymphocytic Leukemia (Ph+ ALL) in the Elderly With Imatinib Mesylate (STI571) and Chemotherapy.
Lead Sponsor:
Hospices Civils de Lyon
Conditions:
Acute Lymphocytic Leukemia
Eligibility:
All Genders
55-90 years
Phase:
PHASE2
Brief Summary
ALL patients aged 55 years or older were treated with steroids during one week and Ph+ve cases were then offered a specific therapy including an induction treatment with steroids, cyclophosphamide, da...
Eligibility Criteria
Inclusion
- Ph+ ALL patients
- 55 years or older
- Signed written informed consent
Exclusion
- CML in transformation
- Concomitant malignancy
- Previous treatment by Imatinib
- Severe organ condition
Key Trial Info
Start Date :
August 1 2002
Trial Type :
INTERVENTIONAL
End Date :
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT00149136
Start Date
August 1 2002
Last Update
April 27 2007
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Xavier THOMAS
Lyon, France, 69437